Harvard Apparatus Regenerative Technology Inc (OTCPK:HRGN)
$ 3.45 0 (0%) Market Cap: 54.92 Mil Enterprise Value: 55.35 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

Q2 2022 Biostage Inc Earnings Call Transcript

Aug 05, 2022 / 01:00PM GMT
Release Date Price: $5
Operator

Greetings, and welcome to the Biostage investor update call. At this time, all participants are in a listen-only mode. Due to the fact that the company is in the SEC-mandated quiet period, there will not be a question-and-answer period today. As a reminder, this conference is being recorded.

Let me now introduce your host, Peter Pellegrino. Thank you, sir. You may begin.

Peter Pellegrino
Biostage, Inc. - Interim VP of Finance

Thank you. Good morning. This is Peter Pellegrino, Interim Vice President of Finance. On the call with me today is David Green, our Interim Chief Executive Officer. Before I turn it over to David, let me review the company's forward-looking statements.

In our discussion today, we will make statements that constitute forward-looking statements. Our actual results and performance may differ materially from what we had previously projected due to the risks and uncertainties including those detailed in our annual report on Form 10-K for the year ended December 31, 2021, and our other public filings including our Form S-1

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot